Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Corvus Pharmaceuticals (CRVS) Receivables - Other (2021 - 2024)

Corvus Pharmaceuticals' Receivables - Other history spans 6 years, with the latest figure at $70000.0 for Q3 2024.

  • Quarterly Receivables - Other changed N/A to $70000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $70000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $26000.0 for FY2023, 95.58% down from the prior year.
  • Receivables - Other came in at $70000.0 for Q3 2024, up from $35000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $588000.0 in Q4 2022 to a low of $26000.0 in Q4 2023.
  • The 4-year median for Receivables - Other is $373000.0 (2022), against an average of $291454.5.
  • Year-over-year, Receivables - Other soared 82.25% in 2022 and then crashed 95.58% in 2023.
  • Corvus Pharmaceuticals' Receivables - Other stood at $507000.0 in 2021, then increased by 15.98% to $588000.0 in 2022, then plummeted by 95.58% to $26000.0 in 2023, then skyrocketed by 169.23% to $70000.0 in 2024.
  • Per Business Quant, the three most recent readings for CRVS's Receivables - Other are $70000.0 (Q3 2024), $35000.0 (Q2 2024), and $26000.0 (Q1 2024).